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Failed Completion of Treatment
for Latent Tuberculosis Infection —
Chickasaw County, Mississippi,
June 1999–March 2002
During June 1999–March 2002, a total of 16 tuberculosis
(TB) cases were reported from Chickasaw County, Missis-
sippi (2000 population: 19,440), corresponding to annual TB
incidences of 20.5–27.6 cases per 100,000 population. In
comparison, annual TB incidences for Mississippi during the
same period decreased from 7.8 to 5.4 cases per 100,000 popu-
lation. This report summarizes the results of an investigation
of the patients and their contacts and demonstrates the need
for strategies to increase the proportion of infected contacts
that successfully complete treatment for latent TB infection
(LTBI).
During April–May 1, 2002, the Mississippi State Depart-
ment of Health (MSDH) conducted an epidemiologic inves-
tigation of the high incidence of TB in Chickasaw County.
Patients were interviewed, and health department medical
records were reviewed for clinical data. Restriction fragment
length polymorphism (RFLP) analysis using IS6110 was per-
formed on all culture isolates. For contacts, LTBI was defined
as infection in a patient with a tuberculin skin test (TST) >5
mm induration and no evidence of TB disease. Contact in-
vestigation logs were reviewed and health department records
used to establish outcomes of treatment for LTBI.
The median age of the 16 TB patients was 31 years (range:
2–64 years); five (31%) were aged <16 years. Ten (63%)
patients were male, and 15 (94%) were black. All 16 TB
patients were born in the United States and were human
immunodeficiency virus (HIV)-seronegative. For 11 patients
from whom sputum specimens were obtained for bacterio-
logic examination, eight (73%) were culture-positive for
Mycobacterium tuberculosis, of whom six (55%) also were spu-
tum-smear positive for acid-fast bacilli. RFLP analysis per-
formed on all eight culture-positive isolates showed seven
(88%) with matching 10-band patterns . The contact investi-
overseas screening of immigrants and refugees, 2) enhance
the notification system that alerts local health departments to
the arrival of immigrants or refugees with suspected TB to
improve diagnosis and treatment, 3) establish a binational TB
referral and case management system for the United States
and Mexico to improve treatment completion by TB patients
who cross the United States–Mexico border (the U.S.–Mexico
Binational TB Referral and Case Management Project), 4)
identify and treat persons arriving from high-incidence coun-
tries who have latent TB infection, and 5) strengthen collabo-
rations with the World Health Organization and other
international partners aimed at improving TB control in high-
incidence countries (the STOP TB Partnership). In support
of these efforts, CDC and its 22 partner research institutes,
clinical centers, and health departments in the United States
and Canada that compose the Tuberculosis Epidemiologic
Studies Consortium have initiated a study to identify missed
opportunities for TB prevention among foreign-born persons.
Although intensified TB control efforts helped reduce the
TB case rate in the U.S.-born non-Hispanic black population
by approximately 70% during 1992–2002, that rate has
remained approximately eight times higher than the rate
among non-Hispanic whites. Because much of this disparity
is associated with socioeconomic status (9), intensified out-
reach programs tailored to the needs of low-income persons
might accelerate TB elimination. CDC is funding demon-
stration projects in South Carolina, Georgia, and Chicago,
Illinois, to identify innovative strategies to improve TB screen-
ing, diagnosis, and treatment adherence in high-risk black
communities.
Elimination of health disparities is one of the national health
goals for 2010 (Goal 2) (10). Closing the gaps in TB rates
will help achieve this and the goal of TB elimination.
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gations and matching RFLP patterns suggest recent transmis-
sion of M. tuberculosis. Isolates from all culture-confirmed
patients were susceptible to first-line anti-TB drugs (isoniazid,
rifampin, pyrazinamide, and ethambutol). All 16 patients
successfully completed a CDC-recommended course of treat-
ment.
Among the 16 TB patients, five had been diagnosed previ-
ously with LTBI as a result of TB contact investigations;
patients ranged in age from 28 to 51 years, and four (80%)
had a history of regular alcohol use. MSDH attempted to
treat all five patients, but all had either refused or stopped
treatment. The patients subsequently progressed to active TB
and became sources of infection for an additional 10 TB pa-
tients, including the five patients aged <16 years.
The 16 TB patients identified 364 contacts (median: 19
contacts per case; range: 6–90). The patients, with the assis-
tance of a health department worker, classified 350 (96%) of
these contacts as either close (63%) or casual (37%). The 364
contacts represented 253 persons. As of May 1, 2002, TST
screening, including if indicated a 10–12 week follow-up TST,
was completed for 230 (91%) of the 253 persons. TST screen-
ing results and subsequent evaluation (including chest radio-
graph, and if indicated, sputum examination) detected LTBI
in 67 (26%) persons. Patients with LTBI were not offered
HIV testing and counseling routinely.
Adults with LTBI were offered a 9-month regimen of daily
self-administered isoniazid, dispensed at 1-month increments.
Directly observed treatment for LTBI was offered both to
children and those adults with known HIV infection. Treat-
ment for LTBI was defined as complete if the patient had
retrieved >6 months of isoniazid and was assessed by a super-
vising nurse as having completed treatment. Among the 67
persons with LTBI diagnosed, treatment was initiated in 57
(85%), discontinued in nine (13%) because of side effects,
and completed in 36 (54%).
As a result of this investigation, patients in Chickasaw
County with untreated LTBI were again offered treatment.
To enhance completion of treatment for LTBI, MSDH hired
additional outreach workers and expanded the use of direct
observation of treatment for LTBI. MSDH staff targeted the
use of direct observation to adult patients considered at high
risk for treatment default, including persons who regularly
used alcohol and those who had interrupted treatment previ-
ously. MSDH also is considering the use of incentives such as
grocery coupons.
To identify barriers to LTBI treatment completion, MSDH
in partnership with CDC, conducted three focus groups with
TB-control staff, patients adherent to treatment for LTBI, and
patients nonadherent to treatment for LTBI. Focus group
participants suggested that TB-control staff persistence and
flexibility helped adherence to treatment for LTBI, as did par-
ticipation of sex and race-matched community outreach work-
ers. Many participants cited community and family stigma as
treatment barriers and identified a need for additional infor-
mation about the importance of LTBI treatment.
To address patient concerns and misconceptions, MSDH
has initiated ongoing individual counseling during treatment
for LTBI. Furthermore, MSDH has engaged community lead-
ers, churches, and civic organizations to disseminate TB-
related educational messages.
Reported by: T Chamblee, D Hartley, M Holcombe, MPPA,
K Parham, P Upchurch, RM Webb, MD, Mississippi Dept of Health.
AG Robillard, PhD, Rollins School of Public Health of Emory Univ,
Atlanta, Georgia. L Diem, B Metchock, PhD, Div of AIDS, STD, and
TB Laboratory Research, National Center for Infectious Diseases; N
DeLuca, MA, PD McElroy, PhD, T Navin, MD, W Walton, MEd,
Div of Tuberculosis Elimination, National Center for HIV, STD, and
TB Prevention; Div of Applied Public Health Training, Epidemiology
Program Office; PK Dewan, MD, EIS Officer, CDC.
Editorial Note: The findings in this investigation underscore
the need to ensure completion of treatment for LTBI by in-
fected contacts of TB patients. Integral components of suc-
cessful contact investigations include patient interview, contact
identification, and medical evaluation for active TB and LTBI
(1), followed by successful initiation and completion of treat-
ment for LTBI.
This investigation found that contact identification and
evaluation were thorough and effective. For example, the
median number of contacts identified and the proportion of
contacts evaluated for LTBI were higher than those found in
five other TB programs in a recent study of contact investiga-
tions (1,2). Despite these efforts, patients with untreated LTBI
subsequently developed active TB and served as the source of
ongoing TB transmission in the community. This contrib-
uted to the persistently high TB incidences in Chickasaw
County.
The discovery of LTBI during contact investigation sug-
gests recent infection. Because the risk for progression from
infection to active disease is highest during the first 2 years
following infection, priority should be given to treating in-
fected contacts identified during contact investigations (3).
Studies among populations at highest risk for loss to follow-
up (e.g., injection-drug users, released jail inmates, and home-
less persons) have shown that the use of incentives and direct
observation of treatment substantially improves LTBI treat-
ment completion rates (4–7). Among high-risk groups, these
interventions might be cost-effective (8). Additional evalua-
tion is needed to determine if patients outside these high-risk
groups might benefit from incentives and direct observation
of treatment. Qualitative evaluation of patient, staff, and sys-
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tem barriers might identify community-specific barriers to
treatment initiation and completion. In Chickasaw County,
focus group findings suggested that ongoing individual coun-
seling for patients with LTBI and efforts to reduce stigma
through community engagement might promote completion
of treatment for LTBI. A follow-up evaluation might help
determine the effectiveness of these interventions.
Completion of treatment for LTBI is the final component
of an effective contact investigation. If the actual number of
infected contacts substantially exceeds those identified and
successfully screened, the treatment completion rate might
overestimate the contact investigation effectiveness (2). To
effectively interrupt M. tuberculosis transmission, successful
implementation of all elements of contact investigation is nec-
essary (8). Treating patients with LTBI increasingly challenges
the response capacity of state and local TB-control programs
(9). Although the decline of TB in blacks has paralleled the
overall national trends, in 2001, incidence among non-His-
panic blacks remained 8.6 times higher than incidence among
whites (10). TB-control programs serving black communities
with high TB incidence should have the resources necessary
to control TB and reduce this health disparity.
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Update: Influenza Activity —
United States, 2002–03 Season
This report summarizes influenza activity in the United
States during September 29, 2002–March 8, 2003,* and
updates the previous summary (1). Influenza activity was mild
in the United States overall but varied by region. Preliminary
data collected through the four components of the CDC
influenza surveillance system suggest that national influenza
activity peaked during the week ending February 8, 2003 (2).
As of the week ending March 8, the World Health Organi-
zation (WHO) and National Respiratory and Enteric Virus
Surveillance System collaborating laboratories in the United
States tested 59,731 specimens for influenza viruses, of which
6,433 (10.8%) were positive. The percentage of specimens
testing positive for influenza exceeded 10.0% during the week
ending January 18 and appears to have peaked at 25.0% dur-
ing the week ending February 8. During the three most
recent influenza seasons (1999–00, 2000–01, and 2001–02),
the peak percentage of specimens testing positive for influ-
enza ranged from 23.9% to 30.9% (3; CDC, unpublished
data, 2003). Of the 6,433 influenza viruses reported during
the 2002–03 season, 2,916 (45.3%) were influenza type A
and 3,517 (54.7%) were influenza type B viruses. However,
during the weeks ending February 22–March 8, influenza A
viruses have been reported more frequently (57.0%) than
influenza B viruses. Of the 1,329 influenza type A viruses
that have been subtyped, 1,089 (81.9%) are influenza A (H1)†
viruses and 240 (18.1%) are influenza A (H3N2) viruses. For
the season, influenza type A viruses have predominated in the
New England, East North Central, Mountain, Pacific, and
Mid-Atlantic regions, and influenza B viruses have predomi-
nated in the West South Central, South Atlantic, West North
Central, and East South Central regions. However, during
the weeks ending February 22–March 8, influenza A viruses
were reported more frequently (71.1%) in the West South
Central region than influenza B viruses.
CDC has characterized antigenically 266 influenza viruses
submitted by U.S. laboratories since September 29, 2002: 65
influenza A (H1) viruses, 54 influenza A (H3N2) viruses, and
147 influenza B viruses. Of the 65 influenza A (H1)
viruses, 45 (69.2%) had the N1 neuraminidase and 20
(30.8%) had the N2 neuraminidase. The hemagglutinin pro-
teins of all 65 influenza A (H1) viruses were similar antigeni-
cally to the hemagglutinin of the vaccine strain A/New
Caledonia/20/99 (H1N1). Of the 54 influenza A (H3N2)
isolates that have been characterized, 47 (87.0%) were similar
to A/Panama/2007/99, the H3N2 component of the 2002–
03 influenza vaccine, and seven (13.0%) showed reduced
* As of March 14, 2003. Reporting is incomplete.
† Includes both the A (H1N1) and A (H1N2) influenza virus subtypes.
